리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2025년 02월
페이지 정보:영문 94 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 다가불포화지방산 시장은 2030년까지 65억 달러에 도달
2024년에 35억 달러로 추정되는 세계의 다가불포화지방산 시장은 2024-2030년에 CAGR 10.9%로 성장하며, 2030년에는 65억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 식이보충제 & 기능성 식품 애플리케이션은 CAGR 11.7%를 기록하며, 분석 기간 종료까지 49억 달러에 달할 것으로 예측됩니다. 애완동물&동물용 사료 애플리케이션 분야의 성장률은 분석 기간 중 CAGR 7.6%로 추정됩니다.
미국 시장은 추정 8억 9,500만 달러, 중국은 CAGR 14.4%로 성장 예측
미국의 다가불포화지방산 시장은 2024년에 8억 9,500만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 15억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 14.4%입니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 7.1%와 8.8%로 예측됩니다. 유럽에서는 독일이 CAGR 약 8.1%로 성장할 것으로 예측됩니다.
세계의 다가불포화지방산(EPA) 시장 - 주요 동향과 촉진요인 정리
Eicosapentaenoic acid(EPA)란 무엇이며, 왜 영양과 건강에 중요한가?
에이코사펜타엔산(EPA)은 주로 지방이 많은 생선과 특정 조류에서 발견되는 오메가 3 지방산입니다. 고도 불포화 지방산인 EPA는 인간의 건강, 특히 심혈관 기능 지원, 염증 억제, 뇌 건강 증진에 중요한 역할을 하며, EPA는 일반적으로 항염증 효과가 인정되어 심혈관 질환, 관절염, 정신 질환 등 다양한 건강 상태를 관리하는 데 중요한 영양소입니다. 또한 EPA는 에이코사노이드라는 생리활성 화합물의 합성에 기여하는 것으로 알려져 있으며, 체내의 다양한 생리적 과정을 조절하는 데 도움을 줍니다.
영양학에서 EPA의 중요성은 EPA의 다양한 건강 효과로 인해 강조되고 있으며, EPA의 규칙적인 섭취는 중성지방 수치를 낮추고 부정맥의 위험을 줄이며 혈압을 낮춤으로써 심장 건강을 개선하는 것과 관련이 있습니다. 또한 EPA는 정신건강에도 중요한 역할을 하며, 충분한 지방산 섭취가 우울증과 불안 증상을 완화하는 데 도움이 될 수 있다는 연구 결과가 있습니다. 소비자들의 건강에 대한 관심이 높아짐에 따라 EPA가 풍부한 식품 및 보충제에 대한 수요가 증가하고 있으며, 이는 EPA 시장의 성장을 주도하고 있습니다.
EPA의 주요 용도와 영양 수요에 대한 대응은?
EPA의 주요 용도는 건강보조식품, 기능성 식품, 의약품, 동물영양 등입니다. 건강기능식품 분야에서는 EPA가 일반적으로 어유 캡슐, 크릴오일, 해조류 오일의 보충제로 판매되고 있습니다. 이들 제품은 심혈관계 건강 유지, 염증 억제 등 다양한 건강상의 이점을 위해 오메가 3 섭취를 늘리고자 하는 소비자를 대상으로 하며, EPA 보충제의 인기는 특히 건강 지향적 성향이 강하거나 특정 건강상 우려를 가진 사람들 사이에서 급증하고 있습니다. 시장 확대로 이어지고 있습니다.
기능성 식품 분야에서는 유제품, 음료, 스낵바 등 다양한 식품에 EPA를 첨가하는 사례가 증가하고 있습니다. 제조업체들은 영양가 있는 건강 증진 제품에 대한 잠재적인 시장을 인식하고 있습니다. 일상적인 식품에 EPA를 첨가함으로써, 브랜드는 유익한 오메가 3 지방산을 식단에 추가할 수 있는 편리한 방법을 찾는 소비자들을 만족시킬 수 있습니다. 이러한 추세는 종합적인 건강 증진을 추구하는 소비자들 사이에서 건강 기능성 식품에 대한 수요가 지속적으로 증가하고 있으므로 특히 중요합니다.
EPA는 제약업계에서도 주목을 받고 있으며, 치료제로의 적용이 검토되고 있습니다. 심혈관 질환, 염증성 질환, 정신 질환 등 다양한 질환의 관리에 있으며, EPA의 효능을 평가하기 위한 연구가 진행 중입니다. 새로운 임상 연구가 진행됨에 따라 EPA의 건강상의 이점을 지원하는 증거가 늘어나고, 이 중요한 지방산을 함유한 새로운 의약품이 개발될 가능성이 있습니다.
또한 동물 영양 분야에서는 반려동물 사료와 양식어에 EPA의 활용이 확대되고 있습니다. 반려동물 영양 분야에서는 관절 건강, 피부 상태, 건강 전반을 지원하기 위해개 사료와 고양이 사료에 EPA가 첨가되고 있습니다. 건강 효과와 고품질 원료를 중시하는 프리미엄 펫푸드 동향이 증가하면서 EPA와 같은 오메가 3 지방산 강화 제품에 대한 수요가 증가하고 있습니다. 양식업에서 EPA는 사료의 품질을 높이고 어류의 건강과 성장률을 향상시키기 때문에 양식어의 성장과 건강에 매우 중요합니다. 지속가능한 방식으로 양식된 어패류에 대한 전 세계적인 수요 증가는 양식용 사료에 EPA의 사용을 더욱 촉진하고 있습니다.
기술의 발전은 EPA 시장에 어떤 영향을 미치고 있는가?
기술의 발전은 생산 방법, 추출 공정 및 제품 배합을 개선하여 EPA 시장에 큰 영향을 미치고 있습니다. 주목할 만한 발전 중 하나는 천연 유래 EPA의 수율과 품질을 향상시키는 추출 기술의 혁신입니다. 초임계 유체 추출 및 저온 압착과 같은 고급 방법을 통해 제조업체는 유익한 특성을 유지하면서 고순도 EPA 오일을 얻을 수 있습니다. 이러한 추출 기술은 EPA의 생산 효율을 향상시킬 뿐만 아니라 기존 추출 방법에 따른 환경 영향을 줄일 수 있습니다.
또한 조류에서 추출한 EPA의 등장은 시장의 판도를 바꾸고 있습니다. EPA와 DHA(docosahexaenoic acid)가 풍부한 조류 오일은 EPA와 DHA를 모두 함유하고 있으며, 채식주의자, 채식주의자, 환경 보호에 관심이 많은 소비자들에게 매력적인 식물성 대안으로 떠오르고 있습니다. 채식주의자, 채식주의자, 환경에 민감한 소비자들에게 어필할 수 있는 식물 유래의 선택지를 제공합니다. 효율적인 조류 배양 및 추출 기술의 개발은 이 분야의 성장을 지원하고 있으며, EPA가 풍부한 제품 시장 가용성을 확대하고 있습니다.
제품 제형의 발전은 EPA 보충제의 효능과 생체 이용률을 향상시키고 있습니다. 유화 및 인캡슐레이션 기술의 혁신으로 인해 체내 흡수가 더 쉽고 안정적이며 생체 이용률이 높은 EPA 제품을 만들 수 있게 되었습니다. 이러한 제제는 EPA 보충제의 전반적인 효과를 향상시키고 소비자 만족도를 높일 수 있습니다. 또한 EPA와 DHA, 항산화제, 비타민 등 다른 유익한 성분을 결합하여 종합적인 건강 솔루션을 원하는 소비자의 선호에 부응하기 위해 EPA와 다른 유익한 성분을 결합한 보충제 제제가 보편화되고 있습니다.
또한 디지털 기술과 데이터 분석은 EPA 시장에서 소비자 참여도를 높이고 제품 개발을 촉진하는 데 일조하고 있습니다. 기업은 소비자 피드백과 시장 조사 데이터를 활용하여 소비자의 취향을 더 잘 이해하고 그에 따라 제품 내용을 조정하는 데 활용하고 있습니다. 이러한 데이터베이스 접근 방식은 제조업체들이 타깃팅된 마케팅 전략을 수립하고 소비자의 진화하는 니즈를 충족하는 혁신적인 EPA 제품을 개발하는 데 도움이 되고 있습니다.
마지막으로 EPA의 건강 효과에 대한 지속적인 연구로 새로운 용도와 치료적 활용 가능성이 발견되고 있습니다. 다양한 건강 상태를 관리하는 데 있으며, EPA의 역할에 대한 과학적 연구가 진행됨에 따라 EPA의 용도는 더욱 확대될 것으로 보입니다. 오메가 3 지방산의 중요성에 대한 인식이 높아지고 건강상의 이점을 지원하는 증거가 증가함에 따라 소비자와 임상 현장 모두에서 EPA가 풍부한 제품에 대한 수요가 증가할 것으로 예상됩니다.
EPA 시장의 성장을 이끄는 요인은 무엇인가?
EPA 시장의 성장은 오메가 3 지방산의 건강 효과에 대한 소비자의 인식 증가, 건강 보조 식품에 대한 수요 증가, 기능성 식품 분야의 확대 등 몇 가지 중요한 요인에 의해 주도되고 있습니다. 주요 촉진요인 중 하나는 심혈관계 건강 지원, 염증 억제, 뇌 기능 증진에 대한 EPA의 역할에 대한 인식이 높아진 것입니다. 소비자들의 건강 지향성이 높아지고 건강 증진에 대한 관심이 높아짐에 따라 EPA 보충제 및 강화 제품에 대한 수요가 증가하고 있습니다.
비만, 심장병, 정신질환과 같은 생활습관 관련 질환의 확산은 EPA에 대한 수요를 더욱 증가시키고 있습니다. 소비자들은 예방적 헬스케어를 원하고 있으며, 오메가 3 보충제, 특히 EPA 섭취가 전반적인 건강 증진에 도움이 되는 것으로 인식되고 있습니다. 이러한 추세는 특히 고령화 사회에서 인지 기능을 유지하고 만성적인 건강 문제를 해결하기 위한 해결책을 찾고 있는 고령화 사회에서 더욱 두드러지게 나타나고 있습니다.
기능성 식품 시장의 확대도 EPA 시장 성장에 기여하는 중요한 요인입니다. 소비자들은 다른 건강상의 이점을 제공하는 식품에 대한 관심이 높아지고 있으며, 이는 EPA 강화 제품에 대한 수요 증가로 이어지고 있습니다. 제조업체들은 유제품, 스낵, 식품 및 음료 등 다양한 식품에 EPA를 첨가하여 이러한 수요에 대응하고 있습니다. 소비자의 바쁜 라이프스타일에 맞는 건강 증진 옵션을 제공할 수 있다는 점이 이 분야의 성장을 촉진하고 있습니다.
또한 지속가능한 식물성 식습관을 추구하는 추세에 따라 조류에서 추출한 EPA 제품에 대한 관심이 높아지고 있습니다. 채식주의자나 비건 채식을 하는 소비자들이 늘어남에 따라 오메가 3 지방산의 대체 공급원에 대한 수요가 증가하고 있으며, EPA와 DHA가 풍부한 해조류 오일은 생선에 의존하지 않고 오메가 3 섭취를 늘리고자 하는 소비자들에게 지속가능하고 윤리적인 선택이 될 수 있습니다. 입니다. 소비자의 선호도가 식물성 원료로 이동함에 따라 EPA 시장은 앞으로도 긍정적인 영향을 받을 것으로 보입니다.
마지막으로 현재 진행 중인 EPA의 치료적 적용을 검토하는 연구와 임상 연구가 시장 성장을 가속하고 있습니다. 특정 건강 상태를 관리하는 데 있으며, EPA의 잠재적 유용성에 대한 새로운 증거가 밝혀짐에 따라 의료 서비스 프로바이더들은 오메가 3 보충제 섭취를 권장하고 있습니다. 이러한 연구 결과들은 임상에서 EPA의 사용을 지원하며, 필수 지방산인 EPA의 폭넓은 수용과 활용에 기여하고 있습니다.
결론적으로, EPA 시장은 EPA의 건강 효과에 대한 소비자의 인식 증가, 건강 보조 식품 및 기능성 식품에 대한 수요 증가, 지속가능한 식물성 영양에 대한 수요 증가로 인해 EPA 시장은 강력한 성장세를 보이고 있습니다. 생산 및 제형화 기술 발전과 EPA의 치료 효과에 대한 지속적인 연구로 인해 EPA 시장의 잠재력은 더욱 높아질 것으로 보입니다. 소비자들이 건강과 웰빙을 우선순위에 두면서 EPA가 풍부한 제품에 대한 수요가 증가하여 영양과 웰빙의 미래를 형성할 것으로 예상됩니다.
부문
용도(식이보충제 및 기능성 식품, 애완동물 및 동물 사료, 유아용 조제분유, 의약품, 기타 용도)
조사 대상 기업의 예(주목 43사)
BASF Nutrition
Croda
DSM
EPAX
GC Rieber Oils
KD Pharma
Orkla Health
Polaris
Shandong Yuwang Pharmaceutical
Sinomega
목차
제1장 조사 방법
제2장 개요
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장의 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트
기타 중동
아프리카
제4장 경쟁
KSA
영문 목차
영문목차
Global Eicosapentaenoic Acid Market to Reach US$6.5 Billion by 2030
The global market for Eicosapentaenoic Acid estimated at US$3.5 Billion in the year 2024, is expected to reach US$6.5 Billion by 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Dietary Supplements & Functional Foods Application, one of the segments analyzed in the report, is expected to record a 11.7% CAGR and reach US$4.9 Billion by the end of the analysis period. Growth in the Pet & Animal Feeds Application segment is estimated at 7.6% CAGR over the analysis period.
The U.S. Market is Estimated at US$895.0 Million While China is Forecast to Grow at 14.4% CAGR
The Eicosapentaenoic Acid market in the U.S. is estimated at US$895.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 14.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.1% and 8.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.
What Is Eicosapentaenoic Acid (EPA), And Why Is It Important in Nutrition and Health?
Eicosapentaenoic acid (EPA) is an omega-3 fatty acid primarily found in fatty fish and certain algae. As a polyunsaturated fatty acid, EPA plays a critical role in human health, particularly in supporting cardiovascular function, reducing inflammation, and promoting brain health. EPA is commonly recognized for its anti-inflammatory properties, making it an important nutrient in the management of various health conditions, including cardiovascular diseases, arthritis, and mental health disorders. Additionally, EPA is known to contribute to the synthesis of bioactive compounds called eicosanoids, which help regulate various physiological processes in the body.
The importance of EPA in nutrition is highlighted by its numerous health benefits. Regular consumption of EPA has been linked to improved heart health by lowering triglyceride levels, reducing the risk of arrhythmias, and decreasing blood pressure. Moreover, EPA plays a significant role in mental health, with studies suggesting that adequate levels of this fatty acid may help alleviate symptoms of depression and anxiety. As consumers become more health-conscious, the demand for EPA-rich foods and supplements is on the rise, driving the growth of the EPA market.
What Are the Main Applications of EPA, And How Do They Cater to Nutritional Needs?
Eicosapentaenoic acid (EPA) has several key applications, primarily in dietary supplements, functional foods, pharmaceuticals, and animal nutrition. In the dietary supplement sector, EPA is commonly available in the form of fish oil capsules, krill oil, and algal oil supplements. These products cater to consumers seeking to enhance their omega-3 intake for various health benefits, such as supporting cardiovascular health and reducing inflammation. The popularity of EPA supplements has surged, particularly among health-conscious individuals and those with specific health concerns, leading to a growing market for these products.
In the functional foods segment, EPA is increasingly being incorporated into a variety of food products, including dairy items, beverages, and snack bars. Manufacturers are recognizing the potential market for health-enhancing products that provide added nutritional value. By fortifying everyday foods with EPA, brands can cater to consumers looking for convenient ways to incorporate beneficial omega-3 fatty acids into their diets. This trend is especially relevant as the demand for healthy, functional foods continues to grow among consumers seeking to improve their overall well-being.
EPA is also gaining attention in the pharmaceutical industry, where it is being explored for its therapeutic applications. Research is ongoing to evaluate the efficacy of EPA in managing various medical conditions, including cardiovascular disease, inflammatory disorders, and mental health issues. As new clinical studies emerge, they contribute to the growing body of evidence supporting the health benefits of EPA, potentially leading to new pharmaceutical formulations that incorporate this important fatty acid.
Additionally, the animal nutrition sector is increasingly utilizing EPA in pet foods and aquaculture. In pet nutrition, EPA is being included in dog and cat food formulations to support joint health, skin condition, and overall well-being. The growing trend of premium pet foods, which emphasize health benefits and high-quality ingredients, is driving demand for products fortified with omega-3 fatty acids like EPA. In aquaculture, EPA is crucial for the growth and health of farmed fish, as it enhances feed quality and improves fish health and growth rates. The rising global demand for sustainably farmed seafood is further promoting the use of EPA in aquaculture feeds.
How Are Technological Advancements Impacting the EPA Market?
Technological advancements are significantly influencing the EPA market by improving production methods, extraction processes, and product formulations. One notable development is the innovation in extraction technologies that enhance the yield and quality of EPA from natural sources. Advanced methods, such as supercritical fluid extraction and cold pressing, enable manufacturers to obtain high-purity EPA oils while preserving their beneficial properties. These extraction techniques not only improve the efficiency of EPA production but also reduce the environmental impact associated with traditional extraction methods.
Moreover, the rise of algae-based sources of EPA is transforming the market landscape. As consumers become more aware of sustainability and ethical sourcing, algae-derived EPA products are gaining traction as a viable alternative to fish-based sources. Algal oil, which is rich in both EPA and docosahexaenoic acid (DHA), provides a plant-based option that appeals to vegetarians, vegans, and environmentally conscious consumers. The development of efficient algal cultivation and extraction technologies is supporting the growth of this segment, expanding the availability of EPA-rich products in the market.
Advancements in product formulation are also enhancing the efficacy and bioavailability of EPA supplements. Innovations in emulsification and encapsulation technologies allow for the creation of more stable and bioavailable EPA products that are easier for the body to absorb. These formulations can improve the overall effectiveness of EPA supplements and enhance consumer satisfaction. Additionally, the combination of EPA with other beneficial ingredients, such as DHA, antioxidants, and vitamins, is becoming increasingly common in supplement formulations, catering to consumer preferences for comprehensive health solutions.
Furthermore, digital technology and data analytics are playing a role in improving consumer engagement and product development within the EPA market. Companies are utilizing consumer feedback and market research data to better understand consumer preferences and tailor their product offerings accordingly. This data-driven approach helps manufacturers create targeted marketing strategies and develop innovative EPA products that meet the evolving needs of consumers.
Finally, ongoing research into the health benefits of EPA is leading to new applications and potential therapeutic uses. As scientific studies continue to explore the role of EPA in managing various health conditions, the market is likely to see an expansion of its applications. Increased awareness of the importance of omega-3 fatty acids, along with growing evidence supporting their health benefits, will likely drive demand for EPA-rich products in both consumer and clinical settings.
What Is Driving the Growth in the EPA Market?
The growth in the EPA market is driven by several key factors, including increasing consumer awareness of the health benefits of omega-3 fatty acids, rising demand for dietary supplements, and the expansion of the functional foods sector. One of the primary drivers is the growing recognition of EPA's role in supporting cardiovascular health, reducing inflammation, and promoting brain function. As consumers become more health-conscious and proactive about their well-being, the demand for EPA supplements and fortified products is on the rise.
The increasing prevalence of lifestyle-related health conditions, such as obesity, heart disease, and mental health disorders, is further fueling the demand for EPA. Consumers are seeking preventive health measures, and omega-3 supplementation, particularly with EPA, is increasingly viewed as a beneficial approach to supporting overall health. This trend is particularly prominent among aging populations who are looking for solutions to maintain cognitive function and manage chronic health issues.
The expansion of the functional foods market is another significant factor contributing to the growth of the EPA market. Consumers are increasingly interested in foods that provide additional health benefits, leading to a rise in demand for EPA-fortified products. Manufacturers are responding to this demand by incorporating EPA into a variety of food items, including dairy products, snacks, and beverages. The ability to offer health-enhancing options that fit into consumers' busy lifestyles is driving the growth of this segment.
Additionally, the trend toward sustainable and plant-based diets is promoting interest in algae-derived EPA products. As more consumers adopt vegetarian and vegan lifestyles, the demand for alternative sources of omega-3 fatty acids is rising. Algal oil, rich in both EPA and DHA, presents a sustainable and ethical option for those seeking to increase their omega-3 intake without relying on fish sources. This shift in consumer preferences toward plant-based solutions is likely to continue influencing the EPA market positively.
Finally, ongoing research and clinical studies investigating the therapeutic applications of EPA are driving market growth. As new evidence emerges regarding the potential benefits of EPA in managing specific health conditions, healthcare providers are increasingly recommending omega-3 supplementation. This growing body of research supports the use of EPA in clinical settings, contributing to the broader acceptance and utilization of this essential fatty acid.
In conclusion, the EPA market is experiencing robust growth driven by increasing consumer awareness of its health benefits, rising demand for dietary supplements and functional foods, and the trend toward sustainable and plant-based nutrition. Technological advancements in production and formulation, coupled with ongoing research into the therapeutic potential of EPA, will further enhance the market's prospects. As consumers prioritize their health and well-being, the demand for EPA-rich products is expected to flourish, shaping the future of nutrition and wellness.
SCOPE OF STUDY:
The report analyzes the Eicosapentaenoic Acid market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Application (Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals, Other Applications)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 43 Featured) -
BASF Nutrition
Croda
DSM
EPAX
GC Rieber Oils
KD Pharma
Orkla Health
Polaris
Shandong Yuwang Pharmaceutical
Sinomega
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Eicosapentaenoic Acid - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Demand for Omega-3 Fatty Acids in Dietary Supplements Drives Growth of Eicosapentaenoic Acid (EPA) Market
Increased Adoption of EPA in Cardiovascular Health Products Expands Addressable Market
Surge in Demand for EPA in Functional Foods and Beverages Fuels Market Growth
Technological Advancements in EPA Extraction from Fish and Algae Propel Market Expansion
Growing Focus on EPA for Anti-Inflammatory and Joint Health Benefits Strengthens Business Case
Rising Use of EPA in Cognitive and Brain Health Supplements Sets the Stage for Market Growth
Surge in Adoption of EPA in Sports Nutrition and Fitness Products Expands Market Opportunities
Growing Demand for EPA in Infant and Maternal Nutrition Expands Addressable Market
Rising Focus on EPA for Eye Health and Vision Support Fuels Market Demand
Technological Advancements in Microencapsulation of EPA for Enhanced Stability Propel Market Growth
Surge in Demand for EPA in Elderly Care and Cognitive Decline Prevention Expands Market Growth
Rising Use of EPA in Animal Nutrition Expands Market Opportunities
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 2: World Historic Review for Eicosapentaenoic Acid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 3: World 15-Year Perspective for Eicosapentaenoic Acid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Dietary Supplements & Functional Foods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 5: World Historic Review for Dietary Supplements & Functional Foods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 6: World 15-Year Perspective for Dietary Supplements & Functional Foods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Infant Formula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 8: World Historic Review for Infant Formula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 9: World 15-Year Perspective for Infant Formula by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 11: World Historic Review for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 12: World 15-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 14: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 15: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 16: World Eicosapentaenoic Acid Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
TABLE 17: World Recent Past, Current & Future Analysis for Pet & Animal Feeds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Pet & Animal Feeds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 19: World 15-Year Perspective for Pet & Animal Feeds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 20: USA Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 21: USA Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 22: USA 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
CANADA
TABLE 23: Canada Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 24: Canada Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 25: Canada 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
JAPAN
Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 26: Japan Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 27: Japan Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 28: Japan 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
CHINA
Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 29: China Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 30: China Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 31: China 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
EUROPE
Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 32: Europe Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 33: Europe Historic Review for Eicosapentaenoic Acid by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 34: Europe 15-Year Perspective for Eicosapentaenoic Acid by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 35: Europe Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 36: Europe Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 37: Europe 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
FRANCE
Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 38: France Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 39: France Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 40: France 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
GERMANY
Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 41: Germany Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 42: Germany Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 43: Germany 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
ITALY
TABLE 44: Italy Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 45: Italy Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 46: Italy 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
UNITED KINGDOM
Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 47: UK Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 48: UK Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 49: UK 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
SPAIN
TABLE 50: Spain Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 51: Spain Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 52: Spain 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
RUSSIA
TABLE 53: Russia Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 54: Russia Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 55: Russia 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 57: Rest of Europe Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 58: Rest of Europe 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 60: Asia-Pacific Historic Review for Eicosapentaenoic Acid by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 61: Asia-Pacific 15-Year Perspective for Eicosapentaenoic Acid by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 63: Asia-Pacific Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 64: Asia-Pacific 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
AUSTRALIA
Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
TABLE 65: Australia Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 66: Australia Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 67: Australia 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
INDIA
Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
TABLE 68: India Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 69: India Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 70: India 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
SOUTH KOREA
TABLE 71: South Korea Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 72: South Korea Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 73: South Korea 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
TABLE 74: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 75: Rest of Asia-Pacific Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 76: Rest of Asia-Pacific 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
LATIN AMERICA
Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
TABLE 77: Latin America Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 78: Latin America Historic Review for Eicosapentaenoic Acid by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 79: Latin America 15-Year Perspective for Eicosapentaenoic Acid by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
TABLE 80: Latin America Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 81: Latin America Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 82: Latin America 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
ARGENTINA
TABLE 83: Argentina Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 84: Argentina Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 85: Argentina 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
BRAZIL
TABLE 86: Brazil Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 87: Brazil Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 88: Brazil 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
MEXICO
TABLE 89: Mexico Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 90: Mexico Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 91: Mexico 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
TABLE 92: Rest of Latin America Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 93: Rest of Latin America Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 94: Rest of Latin America 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
MIDDLE EAST
Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
TABLE 95: Middle East Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 96: Middle East Historic Review for Eicosapentaenoic Acid by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 97: Middle East 15-Year Perspective for Eicosapentaenoic Acid by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
TABLE 98: Middle East Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 99: Middle East Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 100: Middle East 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
IRAN
TABLE 101: Iran Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 102: Iran Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 103: Iran 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
ISRAEL
TABLE 104: Israel Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 105: Israel Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 106: Israel 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
SAUDI ARABIA
TABLE 107: Saudi Arabia Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 108: Saudi Arabia Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 109: Saudi Arabia 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
UNITED ARAB EMIRATES
TABLE 110: UAE Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 111: UAE Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 112: UAE 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
REST OF MIDDLE EAST
TABLE 113: Rest of Middle East Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 114: Rest of Middle East Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 115: Rest of Middle East 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
AFRICA
Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
TABLE 116: Africa Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 117: Africa Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 118: Africa 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030